Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.46 | -$0.45 | -$0.46 |
| Q2 2026 | 3 | -$0.30 | -$0.30 | -$0.30 |
| Q3 2026 | 3 | -$0.23 | -$0.23 | -$0.23 |
| Q4 2026 | 3 | -$0.23 | -$0.23 | -$0.23 |
| Q1 2027 | 1 | -$0.35 | -$0.34 | -$0.34 |
| Q2 2027 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q3 2027 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q4 2027 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q1 2028 | 2 | -$0.35 | -$0.34 | -$0.34 |
| Q2 2028 | 2 | $0.02 | $0.02 | $0.02 |
| Q3 2028 | 2 | $0.28 | $0.28 | $0.28 |
| Q4 2028 | 2 | $0.13 | $0.13 | $0.13 |
OrthoPediatrics corp last posted its earnings results on Tuesday, August 4th, 2026. The company reported $-0.26 earnings per share for the quarter, topping analysts' consensus estimates of $-0.30222 by $0.04222. The company had revenue of 70.51 M for the quarter and had revenue of 236.35 M for the year. OrthoPediatrics corp has generated $-2 earnings per share over the last year ($-1.69 diluted earnings per share) and currently has a price-to-earnings ratio of -13.51. OrthoPediatrics corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/05/2026 | Q2 2026 | N/A | -$0.30 | N/A | $68.21 M | $70.51 M |
| 05/01/2026 | Q1 2026 | N/A | -$0.45 | N/A | $58.29 M | $59.36 M |
| 03/04/2026 | Q4 2025 | N/A | -$0.43 | N/A | $60.16 M | $61.61 M |
| 10/29/2025 | Q3 2025 | N/A | -$0.50 | N/A | $62.11 M | $61.25 M |
| 08/06/2025 | Q2 2025 | N/A | -$0.30 | N/A | $61.47 M | $61.08 M |
| 05/08/2025 | Q1 2025 | N/A | -$0.46 | N/A | $51.68 M | $52.41 M |
| 03/05/2025 | Q4 2024 | N/A | -$0.69 | N/A | $51.32 M | $52.67 M |
| 11/07/2024 | Q3 2024 | N/A | -$0.34 | N/A | $53.73 M | $54.57 M |
| 08/06/2024 | Q2 2024 | N/A | -$0.26 | N/A | $52.52 M | $52.80 M |
| 05/07/2024 | Q1 2024 | N/A | -$0.34 | N/A | $41.78 M | $44.69 M |
| 03/08/2024 | Q4 2023 | N/A | -$0.29 | N/A | $37.73 M | $37.61 M |
| 11/07/2023 | Q3 2023 | N/A | -$0.20 | N/A | $40.37 M | $39.97 M |
| 08/01/2023 | Q2 2023 | N/A | -$0.13 | N/A | $39.13 M | $39.56 M |
| 05/02/2023 | Q1 2023 | N/A | -$0.30 | N/A | $29.31 M | $31.59 M |
| 03/01/2023 | Q4 2022 | N/A | -$0.35 | N/A | $31.00 M | $30.99 M |
| 11/01/2022 | Q3 2022 | N/A | $0.88 | N/A | $36.15 M | $34.95 M |
| 08/04/2022 | Q2 2022 | N/A | -$0.02 | N/A | $32.40 M | $32.93 M |
| 05/05/2022 | Q1 2022 | N/A | -$0.47 | N/A | $22.76 M | $23.42 M |
| 03/03/2022 | Q4 2021 | N/A | $0.00 | N/A | $24.71 M | $24.81 M |
| 11/04/2021 | Q3 2021 | N/A | -$0.11 | N/A | $26.28 M | $25.08 M |
In the previous quarter, OrthoPediatrics corp (:KIDS) reported $-0.26 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.30222 by $0.04222.
The conference call for OrthoPediatrics corp's latest earnings report can be listened to online.
The conference call transcript for OrthoPediatrics corp's latest earnings report can be read online.
OrthoPediatrics corp (:KIDS) has a recorded annual revenue of $236.35 M.
OrthoPediatrics corp (:KIDS) has a recorded net income of $-39,648,000.OrthoPediatrics corp has generated $-1.69 earnings per share over the last four quarters.
OrthoPediatrics corp (:KIDS) has a price-to-earnings ratio of -13.51 and price/earnings-to-growth ratio is -3.54.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED